Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03JCA
|
|||
| Former ID |
DIB003870
|
|||
| Drug Name |
MB-11055
|
|||
| Synonyms |
Cryptotanshinone, MD BioAlpha; Cryptotanshinone, Mazence; AMP activated protein kinase stimulator (liver cirrhosis/steatosis/steatohepatitis), Mazence; AMPK stimulator (liver cirrhosis/steatosis/steatohepatitis), Mazence; Lipid metabolism stimulator (liver cirrhosis/steatosis/steatohepatitis), Mazence
Click to Show/Hide
|
|||
| Indication | Fatty liver disease [ICD-11: DB92.Z] | Phase 2 | [1] | |
| Company |
Mazence Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035046) | |||
| REF 2 | Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase.Mol Pharmacol.2007 Jul;72(1):62-72. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.